University of California, Los Angeles   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Los Angeles California United States (1919)
First Clinical Trial
1990
NCT00000136
First Marketed Drug
2013
fludeoxyglucose f-18
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Trials (805 total)

Trial APIs (653 total)

Trial Indications (413)

Abscess (Phase 4)

Acne Vulgaris (Phase 3)

Acquired Immunodeficiency Syndrome (Phase 2)

ACTH-Secreting Pituitary Adenoma (Phase 2)

Acute Kidney Injury (Phase 1)

Acute Pain (Phase 3)

Adenocarcinoma (Phase 2)

Adenocarcinoma of Lung

Adenomyosis (Phase 4)

Adrenoleukodystrophy (Phase 3)

AIDS Dementia Complex (Phase 3)

Alcohol Drinking (Phase 4)

Alcoholism (Phase 4)

Alopecia

Alopecia Areata

Alzheimer Disease (Phase 4)

Amphetamine-Related Disorders (Phase 2)

Anemia (Phase 4)

Anemia, Sickle Cell (Phase 2)

Anhedonia (Phase 2)

Anterior Cruciate Ligament Injuries (Phase 1)

Anxiety Disorders (Phase 4)

Aortic Arch Syndromes

Appendicitis (Phase 1)

Arteriosclerosis (Phase 4)

Arteritis

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Asthenozoospermia (Phase 3)

Asthma (Phase 4)

Astrocytoma (Phase 3)

Ataxia (Phase 3)

Atherosclerosis (Phase 3)

Attention Deficit Disorder with Hyperactivity (Phase 4)

Autism Spectrum Disorder (Phase 4)

Autistic Disorder (Phase 3)

Autoimmune Diseases

Behavior, Addictive (Phase 1)

Bile Duct Neoplasms (Phase 3)

Bipolar Disorder (Phase 4)

Birth Weight (Phase 3)

Blast Crisis (Phase 2)

Blindness (Phase 2)

Brachial Plexus Neuritis (Phase 4)

Brain Diseases (Phase 2)

Brain Injuries (Phase 2)

Brain Injuries, Traumatic (Phase 2)

Brain Neoplasms (Phase 3)

Breast Carcinoma In Situ (Phase 2)

Breast Neoplasms (Phase 4)

Breast Neoplasms, Male (Phase 2)

Bronchiolitis

Bronchitis (Phase 4)

Bronchitis, Chronic (Phase 4)

Bronchopulmonary Dysplasia (Phase 3)

Cachexia (Phase 2)

Calcinosis (Phase 4)

Carcinoma (Phase 2)

Carcinoma, Ductal (Phase 1)

Carcinoma, Hepatocellular (Phase 2)

Carcinoma in Situ (Phase 3)

Carcinoma, Neuroendocrine (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 3)

Carcinoma, Renal Cell (Phase 3)

Carcinoma, Small Cell (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Carcinoma, Transitional Cell (Phase 2)

Carcinoma, Verrucous (Phase 2)

Cardiomyopathies

Cardiomyopathy, Dilated

Cardiovascular Diseases (Phase 4)

Carotid Body Tumor (Phase 3)

Cataract

Cellulitis (Phase 2)

Central Nervous System Neoplasms (Phase 2)

Cerebellar Ataxia (Phase 3)

Cerebral Hemorrhage (Phase 2)

Cerebral Palsy (Phase 4)

Child Development Disorders, Pervasive (Phase 4)

Cholangiocarcinoma (Phase 3)

Cholestasis (Phase 4)

Chordoma (Phase 2)

Chronic Kidney Disease-Mineral and Bone Disorder (Phase 2)

Chronic Pain (Phase 3)

Cicatrix (Phase 2)

Clostridium Infections (Phase 2)

Cocaine-Related Disorders (Phase 3)

Coccidioidomycosis (Phase 3)

Coccidiosis (Phase 3)

Cognition Disorders (Phase 4)

Cognitive Dysfunction (Phase 4)

Colonic Neoplasms (Phase 3)

Colorectal Neoplasms (Phase 3)

Communicable Diseases (Phase 2)

Compulsive Personality Disorder (Phase 3)

Corneal Ulcer (Phase 3)

Coronary Artery Disease (Phase 3)

Coronary Disease

Coronary Stenosis (Phase 3)

Craniocerebral Trauma (Phase 4)

Crohn Disease (Phase 2)

Cystadenocarcinoma, Serous (Phase 2)

Death

Death, Sudden, Cardiac

Delirium (Phase 4)

Dementia (Phase 3)

Dental Caries (Phase 3)

Dental Pulp Diseases (Phase 1)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Depressive Disorder, Treatment-Resistant (Phase 4)

Dermatitis

Dermatitis, Atopic

Developmental Disabilities (Phase 4)

Diabetes, Gestational

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2

Digestive System Diseases (Phase 4)

Disease (Phase 4)

Disease Progression (Phase 2)

Distal Myopathies (Phase 2)

Drug-Related Side Effects and Adverse Reactions (Phase 2)

Dwarfism

Dysphonia (Phase 2)

Dyspnea (Phase 4)

Eczema

Eisenmenger Complex

Emergence Delirium (Phase 4)

Emphysema (Phase 4)

Enterobacteriaceae Infections (Phase 1)

Enterocolitis (Phase 3)

Enterocolitis, Necrotizing (Phase 3)

Epilepsy (Phase 2)

Epistaxis (Phase 4)

Erythema

Esophageal Neoplasms (Phase 3)

Eye Diseases (Phase 4)

Facial Pain (Phase 4)

Failure to Thrive

Fallopian Tube Neoplasms (Phase 2)

Familial Primary Pulmonary Hypertension (Phase 4)

Fatigue (Phase 4)

Fever (Phase 3)

Fibromyalgia (Phase 4)

Fibrosis (Phase 4)

Fractures, Bone (Phase 4)

Fractures, Closed (Phase 4)

Fragile X Syndrome (Phase 2)

Friedreich Ataxia (Phase 3)

Gallbladder Neoplasms (Phase 3)

Gambling (Phase 2)

Gastrointestinal Diseases (Phase 4)

Gastrointestinal Stromal Tumors (Phase 2)

Glaucoma (Phase 4)

Glaucoma, Open-Angle (Phase 4)

Glioblastoma (Phase 3)

Glioma (Phase 3)

Gliosarcoma (Phase 2)

Glucose Intolerance

Graft vs Host Disease (Phase 2)

Granuloma (Phase 2)

Granulomatous Disease, Chronic (Phase 2)

Graves Ophthalmopathy (Phase 4)

Headache

Head and Neck Neoplasms (Phase 2)

Head Injuries, Closed (Phase 4)

Heart Defects, Congenital

Heart Diseases (Phase 4)

Heart Failure (Phase 4)

Helicobacter Infections (Phase 3)

Hemoglobinuria (Phase 3)

Hemoglobinuria, Paroxysmal (Phase 3)

Hemophilia A (Phase 4)

Hemorrhage (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis, Alcoholic (Phase 2)

Hepatitis B

Hepatitis B, Chronic

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 2)

Hepatorenal Syndrome (Phase 1)

Heroin Dependence (Phase 3)

Hip Dislocation (Phase 4)

Hip Dislocation, Congenital (Phase 4)

HIV Infections (Phase 4)

HIV Seropositivity (Phase 2)

Hoarseness (Phase 2)

Hodgkin Disease (Phase 3)

Hot Flashes (Phase 3)

Humeral Fractures (Phase 4)

Hyperalgesia (Phase 2)

Hyperandrogenism (Phase 2)

Hypercholesterolemia (Phase 3)

Hyperkinesis (Phase 4)

Hyperparathyroidism (Phase 2)

Hyperparathyroidism, Secondary (Phase 2)

Hyperplasia (Phase 3)

Hypertension (Phase 4)

Hypertension, Pulmonary (Phase 4)

Hypertriglyceridemia

Hypoalbuminemia (Phase 3)

Hypogonadism (Phase 4)

Idiopathic Pulmonary Fibrosis (Phase 4)

Immunologic Deficiency Syndromes (Phase 3)

Infant, Newborn, Diseases (Phase 3)

Infections (Phase 2)

Infertility (Phase 1)

Infertility, Male (Phase 1)

Inflammation (Phase 3)

Influenza, Human (Phase 1)

Intermittent Claudication (Phase 4)

Irritable Bowel Syndrome (Phase 2)

Ischemia

Keratitis (Phase 3)

Kidney Diseases (Phase 3)

Kidney Neoplasms (Phase 3)

Lacerations (Phase 4)

Lambert-Eaton Myasthenic Syndrome (Phase 3)

Laryngeal Diseases (Phase 2)

Laryngeal Neoplasms (Phase 2)

Leiomyoma (Phase 4)

Leukemia (Phase 3)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)

Leukemia, Lymphoid (Phase 3)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 3)

Leukemia, Myeloid (Phase 3)

Leukemia, Myeloid, Acute (Phase 2)

Leukemia, Myeloid, Chronic-Phase (Phase 2)

Leukoplakia (Phase 2)

Leukoplakia, Oral (Phase 2)

Lipodystrophy (Phase 2)

Liver Diseases

Liver Neoplasms (Phase 2)

Lower Urinary Tract Symptoms (Phase 3)

Lung Diseases (Phase 4)

Lung Diseases, Interstitial (Phase 4)

Lung Diseases, Obstructive (Phase 4)

Lung Neoplasms (Phase 2)

Lupus Erythematosus, Systemic (Phase 2)

Lymphocytosis (Phase 4)

Lymphoma (Phase 3)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Follicular (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Mantle-Cell (Phase 1)

Lymphoma, Non-Hodgkin (Phase 3)

Lymphoma, T-Cell (Phase 2)

Lymphoma, T-Cell, Cutaneous (Phase 2)

Lymphoproliferative Disorders (Phase 3)

Lysosomal Storage Diseases (Phase 1)

Machado-Joseph Disease (Phase 3)

Macular Degeneration (Phase 4)

Malnutrition (Phase 3)

Melanoma (Phase 3)

Memory Disorders (Phase 3)

Meningioma (Phase 1)

Mental Disorders (Phase 4)

Metabolic Diseases (Phase 4)

Metrorrhagia (Phase 4)

Migraine Disorders (Phase 3)

Morphine Dependence (Phase 3)

Mouth Diseases (Phase 2)

Mucopolysaccharidoses (Phase 1)

Mucopolysaccharidosis I (Phase 1)

Mucositis (Phase 2)

Multiple Myeloma (Phase 3)

Multiple Sclerosis (Phase 2)

Multiple Sclerosis, Chronic Progressive (Phase 2)

Multiple Sclerosis, Relapsing-Remitting (Phase 2)

Muscular Atrophy (Phase 2)

Muscular Diseases (Phase 2)

Myasthenic Syndromes, Congenital

Myelodysplastic Syndromes (Phase 3)

Myeloproliferative Disorders (Phase 3)

Myocardial Ischemia (Phase 3)

Myofascial Pain Syndromes (Phase 4)

Myofibroma (Phase 4)

Myopia (Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 3)

Neoplasms, Plasma Cell (Phase 3)

Nervous System Neoplasms (Phase 2)

Neuralgia (Phase 4)

Neurilemmoma (Phase 2)

Neurocognitive Disorders (Phase 3)

Neuroendocrine Tumors (Phase 2)

Neurofibroma (Phase 2)

Neurofibromatoses (Phase 2)

Neurofibromatosis 1 (Phase 2)

Neurofibromatosis 2 (Phase 2)

Neuroma (Phase 2)

Neuroma, Acoustic (Phase 2)

Neutropenia (Phase 3)

Nystagmus, Pathologic (Phase 2)

Obesity

Obsessive-Compulsive Disorder (Phase 3)

Obstetric Labor, Premature

Oligodendroglioma (Phase 2)

Oligospermia (Phase 3)

Opioid-Related Disorders (Phase 3)

Optic Atrophy, Hereditary, Leber (Phase 2)

Optic Nerve Diseases (Phase 2)

Oral Ulcer (Phase 2)

Oropharyngeal Neoplasms (Phase 2)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Osteopetrosis (Phase 2)

Ovarian Neoplasms (Phase 3)

Overweight

Pain, Postoperative (Phase 4)

Pain, Procedural (Phase 4)

Pancreatic Neoplasms (Phase 2)

Panic Disorder (Phase 4)

Papilloma (Phase 2)

Papillomavirus Infections (Phase 2)

Paraganglioma (Phase 3)

Paralysis (Phase 4)

Parkinson Disease (Phase 3)

Pemphigus (Phase 2)

Peripheral Arterial Disease (Phase 4)

Peritoneal Neoplasms (Phase 2)

Pheochromocytoma (Phase 3)

Phobia, Social (Phase 4)

Pituitary ACTH Hypersecretion (Phase 2)

Pituitary Diseases (Phase 2)

Pituitary Neoplasms (Phase 2)

Plasmacytoma (Phase 2)

Pneumonia (Phase 2)

Polycystic Ovary Syndrome (Phase 2)

Post-Traumatic Headache (Phase 4)

Precancerous Conditions (Phase 3)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Prediabetic State (Phase 3)

Preleukemia (Phase 3)

Premature Birth (Phase 3)

Prostatic Hyperplasia (Phase 3)

Prostatic Neoplasms (Phase 3)

Protein-Energy Malnutrition (Phase 3)

Psychomotor Agitation (Phase 4)

Psychotic Disorders (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Pulmonary Emphysema (Phase 4)

Pulmonary Fibrosis (Phase 4)

Pulmonary Valve Insufficiency (Phase 2)

Recurrence (Phase 2)

Renal Insufficiency (Phase 1)

Renal Insufficiency, Chronic (Phase 3)

Reperfusion Injury

Respiratory Distress Syndrome, Adult (Phase 2)

Respiratory Distress Syndrome, Newborn (Phase 2)

Respiratory Insufficiency (Phase 2)

Retinal Diseases (Phase 3)

Retinopathy of Prematurity (Phase 3)

Rhabdomyosarcoma (Phase 1)

Rupture

Sarcoma (Phase 2)

Sarcoma, Ewing

Schizophrenia (Phase 4)

Scleroderma, Diffuse (Phase 4)

Scleroderma, Localized (Phase 2)

Scleroderma, Systemic (Phase 4)

Sclerosis (Phase 4)

Seizures (Phase 2)

Severe Combined Immunodeficiency (Phase 2)

Signs and Symptoms (Phase 4)

Signs and Symptoms, Digestive (Phase 4)

Skin Diseases, Infectious (Phase 2)

Skin Neoplasms (Phase 1)

Sleep Apnea, Obstructive (Phase 4)

Sleep Initiation and Maintenance Disorders (Phase 4)

Small Cell Lung Carcinoma (Phase 2)

Soft Tissue Infections (Phase 2)

Spinal Cord Compression (Phase 1)

Spinocerebellar Ataxias (Phase 3)

Spinocerebellar Degenerations (Phase 3)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Stomach Neoplasms (Phase 3)

Stomatitis (Phase 2)

Stress Disorders, Post-Traumatic (Phase 4)

Stress Disorders, Traumatic (Phase 4)

Stroke (Phase 3)

Substance-Related Disorders (Phase 3)

Substance Withdrawal Syndrome (Phase 3)

Syndrome (Phase 4)

Syphilis (Phase 2)

Systemic Inflammatory Response Syndrome (Phase 3)

Takayasu Arteritis

Teratozoospermia (Phase 3)

Thalassemia (Phase 2)

Thyroid Diseases (Phase 4)

Thyroid Neoplasms

Tibial Fractures

Tic Disorders

Tissue Adhesions (Phase 2)

Tobacco Use Disorder (Phase 2)

Tourette Syndrome

Ulcer (Phase 2)

Urethral Neoplasms (Phase 1)

Urinary Bladder Neoplasms (Phase 3)

Uterine Cervical Neoplasms (Phase 3)

Uterine Hemorrhage (Phase 4)

Vascular Diseases (Phase 4)

Vertigo (Phase 3)

Vitamin D Deficiency (Phase 2)

Vomiting (Phase 3)

Waldenstrom Macroglobulinemia (Phase 2)

Wasting Syndrome (Phase 2)

Wet Macular Degeneration (Phase 4)

Wounds and Injuries (Phase 2)

Marketed Drugs (3)

Drugs in Phase 4 Trials (120)

Drugs in Phase 3 Trials (130)

Drugs in Phase 2 Trials (246)

177lu-psma-617 (1 trial)

18f-dopa (2 trials)

abemaciclib (verzenio) (1 trial)

abiraterone (zytiga) (2 trials)

aee-788 (1 trial)

afatinib (gilotrif) (1 trial)

afp peptides (2 trials)

alemtuzumab (campath) (2 trials)

allogeneic cd34+ cells (1 trial)

allogeneic cd3+ cells (1 trial)

allogeneic hematopoietic stem cells (Hemacord) (3 trials)

allogeneic lymphocytes (1 trial)

allogeneic pancreatic islet cells (2 trials)

alpha fetoprotein adenoviral vector vaccine (1 trial)

alprostadil (prostin) (1 trial)

alteplase (Activase) (2 trials)

amantadine (symmetrel) (1 trial)

amg-157 (1 trial)

amifostine (ethyol) (2 trials)

anakinra (kineret) (2 trials)

anastrozole (arimidex) (1 trial)

ans-6637 (1 trial)

apalutamide (erleada) (1 trial)

arbaclofen (4 trials)

arginine (2 trials)

atezolizumab (tecentriq) (1 trial)

autologous cd34+ cells (2 trials)

autologous cd34+ cell transduced with g2scid vector (1 trial)

autologous efs-ada lv cd34+ cells (1 trial)

autologous expanded mesenchymal stem cells oti-010 (1 trial)

axicabtagene ciloleucel (Yescarta) (1 trial)

azathioprine (imuran) (1 trial)

azd-7325 (1 trial)

azficel-T (Laviv) (2 trials)

baclofen (lioresal) (1 trial)

bay383441 (1 trial)

benzathine penicillin (1 trial)

beta-hydroxybutyrate (1 trial)

bezlotoxumab (zinplava) (1 trial)

binimetinib (mektovi) (3 trials)

birinapant (1 trial)

bortezomib (velcade) (7 trials)

bovine type i collagen (1 trial)

brivudine phosphoramidate (1 trial)

buparlisib (1 trial)

busulfan (myleran) (3 trials)

cabergoline (dostinex) (1 trial)

cal-1 modified cd4+ t lymphocytes (1 trial)

cal-1 modified hspc (1 trial)

calcitriol (rocaltrol) (2 trials)

calcium carbonate (1 trial)

cannabidiol (Epidiolex) (3 trials)

carbamazepine (tegretol) (1 trial)

carglumic acid (carbaglu) (2 trials)

cat epidermis allergen (2 trials)

cefixime (suprax) (1 trial)

cemiplimab (libtayo) (1 trial)

ceritinib (zykadia) (1 trial)

cetuximab (erbitux) (2 trials)

cobicistat (stribild) (1 trial)

colchicine (colbenemid) (1 trial)

cp-547632 (1 trial)

curcumin (5 trials)

cyclosporine (sandimmune) (4 trials)

cytarabine (cytosar-u) (5 trials)

dacarbazine (dtic-dome) (2 trials)

da jian zhong tang (1 trial)

dalfampridine (ampyra) (1 trial)

danusertib (1 trial)

dasatinib (sprycel) (5 trials)

daunorubicin (cerubidine) (3 trials)

davunetide (1 trial)

decaffeinated black tea (1 trial)

degarelix acetate (firmagon) (2 trials)

dendritic cell-mart-1 peptide vaccine (2 trials)

dendritic cells (2 trials)

denileukin diftitox (ontak) (1 trial)

dexamethasone (1 trial)

dipyridamole (persantine) (1 trial)

dopamine (intropin) (1 trial)

doxercalciferol (hectorol) (1 trial)

durvalumab (imfinzi) (4 trials)

ecopipam (1 trial)

efs-ada transduced cd34+ bone marrow cells (1 trial)

elamipretide (1 trial)

ellagic acid (1 trial)

elvitegravir (vitekta) (1 trial)

enasidenib (idhifa) (1 trial)

encorafenib (braftovi) (1 trial)

endotoxin (6 trials)

entinostat (1 trial)

enzalutamide (xtandi) (1 trial)

erlotinib (tarceva) (8 trials)

etoposide (vepesid) (3 trials)

everolimus (zortress) (3 trials)

evofosfamide (1 trial)

f5 tcr transgenic cells (1 trial)

farampator (1 trial)

fddnp (1 trial)

fenfluramine (Pondimin) (2 trials)

fibrinolysin, human (1 trial)

fish oil (Omegavan) (2 trials)

florbenazine (1 trial)

Fluciclovine (Axumin) (1 trial)

fludarabine (fludara) (12 trials)

fludeoxyglucose f-18 (8 trials)

flunisolide (nasalide) (1 trial)

flutamide (eulexin) (1 trial)

folic acid (2 trials)

forodesine (1 trial)

fulvestrant (faslodex) (2 trials)

gallium-68-dotatate (netspot) (2 trials)

ganitumab (3 trials)

gc1008 (2 trials)

gcs-100 (1 trial)

gefitinib (iressa) (1 trial)

gemcitabine (gemzar) (5 trials)

gemtuzumab ozogamicin (mylotarg) (2 trials)

genistein (1 trial)

glatiramer acetate (copaxone) (1 trial)

glucose (1 trial)

glycerone phosphate (1 trial)

gm602 (1 trial)

grape (1 trial)

green tea (1 trial)

gs-cda1 (1 trial)

hemicellulose (1 trial)

hydrocortisone (solu-cortef) (1 trial)

ibudilast (5 trials)

idarubicin (idamycin) (1 trial)

ifosfamide (ifex) (2 trials)

imatinib (gleevec) (5 trials)

indocyanine green (ic-green) (1 trial)

infliximab (remicade) (2 trials)

ino-6145 (1 trial)

ino-9012 (1 trial)

interferon alpha-2b (2 trials)

interferon gamma-1b (actimmune) (1 trial)

in vitro-treated peripheral blood stem cell (1 trial)

ioflupane i-123 (1 trial)

ipilimumab (yervoy) (3 trials)

ipratropium (atrovent) (1 trial)

ivermectin (stromectol) (1 trial)

kc706 (1 trial)

lactic acid (1 trial)

lapatinib (tykerb) (3 trials)

leflunomide (arava) (1 trial)

lentiviral g1xcgd (1 trial)

letrozole (femara) (3 trials)

leuprolide (lupron) (1 trial)

leuvectin (2 trials)

lintuzumab (1 trial)

lorazepam (ativan) (1 trial)

ma09-hrpe (1 trial)

mart-1 peptide pulsed dendritic cells (1 trial)

mdma (1 trial)

melanoma peptide-pulsed dendritic cells (1 trial)

melatonin (2 trials)

mesna (mesnex) (1 trial)

methoxy polyethylene glycol-epoetin beta (Mircera) (1 trial)

midostaurin (rydapt) (1 trial)

mk-0777 (1 trial)

modafinil (provigil) (2 trials)

msk-2206 (1 trial)

mva-muc1-il2 (2 trials)

nbtxr3 (1 trial)

necitumumab (portrazza) (1 trial)

niraparib (zejula) (1 trial)

nitrazepam (1 trial)

nitroglycerin (transderm-nitro) (1 trial)

nivolumab (opdivo) (9 trials)

norethisterone (Norlutin) (1 trial)

ny-eso-1 reactive tcr retroviral vector transduced autologous pbl (3 trials)

ocriplasmin (jetrea) (1 trial)

omegavan (1 trial)

oregovomab (1 trial)

osimertinib (tagrisso) (2 trials)

oxaloacetate (1 trial)

paclitaxel (taxol) (10 trials)

palbociclib (ibrance) (1 trial)

palifermin (kepivance) (1 trial)

pamrevlumab (2 trials)

panitumumab (vectibix) (3 trials)

panobinostat (farydak) (2 trials)

pazopanib (votrient) (1 trial)

pegademase-bovine (1 trial)

pembrolizumab (keytruda) (8 trials)

pemetrexed (alimta) (3 trials)

pennvax-g dna vaccine (1 trial)

pentobarbital (nembutal) (1 trial)

pentostatin (nipent) (1 trial)

peripheral blood hematopoietic cell (5 trials)

picoplatin (1 trial)

pirfenidone (esbriet) (1 trial)

poly-iclc (2 trials)

pomalidomide (pomalyst) (1 trial)

pomegranate extract (6 trials)

pomx (2 trials)

prednisone (meticorten) (2 trials)

progestin (1 trial)

propranolol (inderal) (1 trial)

pyridoxine (1 trial)

pyruvate (1 trial)

relatlimab (1 trial)

resiquimod (1 trial)

revefenacin (yupelri) (1 trial)

ribavirin (virazole) (2 trials)

rituximab (rituxan) (7 trials)

rpi.4610 (1 trial)

rp-l201 (1 trial)

sarcosine (2 trials)

sargramostim plasmid dna hepatocellular carcinoma vaccine adjuvant (1 trial)

sb623 (1 trial)

sch66336 (1 trial)

sd-101 (1 trial)

sevelamer (renagel) (2 trials)

sialic acid (1 trial)

sirolimus (rapamune) (4 trials)

sodium dichloroacetate (1 trial)

somatropin (asellacrin) (1 trial)

sontuzumab (2 trials)

sorafenib (nexavar) (2 trials)

squalamine (1 trial)

st1481 (1 trial)

succinylestriol (3 trials)

sucrose (1 trial)

sulfamethoxazole (gantanol) (1 trial)

sunitinib (sutent) (3 trials)

ta-2005 (1 trial)

talazoparib (talzenna) (2 trials)

telmisartan (micardis) (2 trials)

temsirolimus (torisel) (2 trials)

tesamorelin (egrifta) (1 trial)

topotecan (hycamtin) (1 trial)

tosedostat (1 trial)

trametinib (mekinist) (4 trials)

trans sodium crocetinate (1 trial)

tremelimumab (5 trials)

trimethoprim (1 trial)

trivirus specific ctls for ebv, cmv and adenovirus infection (1 trial)

valaciclovir (Valtrex) (1 trial)

vgx-3100 (1 trial)

vincristine (oncovin) (2 trials)

vinorelbine (navelbine) (2 trials)

volociximab (3 trials)

zarnestra (1 trial)

Drugs in Phase 1 Trials (101)

Drugs in Other Trials (56)

Alternative names

Ahmanson / UCLA Adult Congenital Heart Disease Center | Brain Tumor Imaging, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA | Center for AIDS Research and Education, University of California, Los Angeles | Center for Human Nutrition, UCLA David Geffen School of Medicine | Cousins Center for Psychoneuroimmunology, University of California, Los Angeles | David Geffen School of Medicine at UCLA, USA | David Geffen School of Medicine, UCLA | David Geffen - UCLA School of Medicine | Department of Economics, UCLA | Department of Pediatrics, University of California Los Angeles | Department of Psychiatry, Harbor-UCLA Medical Center, California, U.S.A | Department of Psychiatry, Harbor-UCLA Medical Center, Torrance, California | Department of Psychology, UCLA | Department of Pulmonology and Critical Care at David Geffen School of Medicine at UCLA | Desert Pacific Mental Illness Research Education and Clinical Center Semel Institute for Neuroscience at UCLA | Digestive Health and Nutrition Clinic. University of California, Los Angeles, CA, USA | Division of Pulmonary & Critical Care, Department of Medicine, RM# 37-131 CHS, David Geffen School of Medicine/UCLA. 90095-1690 | Division of Rheumatology, Allergy, and Immunology, University of California, Los Angeles | Division of Rheumatology, Department of Medicine, University of California, Los Angeles | Donald B. Kohn, M.D. | Donald E. Morisky | Dr. Veena Ranganath | Fady M Kaldas, M.D., F.A.C.S. | Geffen School of Medicine, University of California, Los Angeles (UCLA) | General Clinical Research Center - Harbor UCLA Medical center | Harbor UCLA | Harbor-UCLA Medical Center (LABiomed) | Harbor-UCLA Medical Center, Los Angeles Biomedical Research Institute | Harbor-UCLA Research & Education Institute | Institute of Urologic Oncology at UCLA | Jeffrey L. Saver | Jeffrey Veale, MD | Jonsson Comprehensieve Cancer Center | Jonsson Comprehensive Cancer Center | Jules Stein Eye Institute and Harbor-UCLA Medical Center | Jules Stein Eye Institute, University of California Los Angeles | Kern Medical Center | Kern Medical Center, David Geffen School of Medicine, UCLA | Kern Medical Center UCLA | LABioMed at Harbor-UCLA | LaBiomed At Harbor-UCLA Medical Center | LABioMed at Harbor-UCLA Medical Center | LABiomedical Research Institute at Harbor-UCLA Medical Center | LA BioMedical Research Institute, Harbor-UCLA | Los Angeles Biomedical Institute | Los Angeles Biomedical Institute at Harbor-UCLA | Los Angeles BioMedical Research Center at Harbor-UCLA | Los Angeles Biomedical Research Institute at Harbor-UCLA | Los Angeles Biomedical Research Institute at Harbor - University of Los Angeles Medical Center | Los Angeles Biomedical Research Institute (LABioMed) | Los Angeles Orthopaedic Hospital | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Mary S. Easton Center for Alzheimer's Disease Research at UCLA | Mattel Children's Hospital of UCLA | Meghan Pearl, MD | Michael Irwin, MD | Michael Roth | Olive View-UCLA Education & Research Institute | Oppenheimer Family Center for Neurobiology of Stress at UCLA | Oppenheimer Family Center of Neurobiology of Stress, UCLA | Paul Finn | Rapoport, Alan, M.D. | Revlon/UCLA Breast Center | Rheumatology Division, UCLA Medical School | Richard C Reznichek, MD | Robert W. Baloh | Ronald Reagan UCLA Medical Center | Ronald Reagan UCLA Medical Center Los Angeles, CA | Semel Institute for Neuroscience and Human Behavior at UCLA | Suzanne Kafaja | UCLA AIDS Prevention & Treatment CTU | UCLA and Western Los Angles VA | UCLA BIOMEDICAL | UCLA CARE Center CRS | UCLA Center for AIDS Research and Educationi | UCLA Center for Clinical AIDS Research and Education | UCLA Center for Human Nutrition | UCLA Center for Neurovisceral Sciences and Women's Health | UCLA Clinical AIDS Research and Education (CARE) Center | UCLA CURE Digestive Diseases Research Center | UCLA David Geffen School of Medicine | UCLA David Geffen School of Medicine and Fielding School of Public Health | UCLA David Geffen School of Medicine, Division of Rheumatology | UCLA Department of Anesthesiology | UCLA Department of Dermatology | UCLA Department of Family Medicine | UCLA Department of Medicine | UCLA Department of Medicine, Division of Clinical Nutrition | UCLA Department of Molecular and Medical Pharmacology | UCLA Department of Psychiatry and Biobeavioral Sciences | UCLA Department of Surgery | UCLA Dept of Family Medicine | UCLA-Dept of Medicine a Div of Hem/Onc | UCLA Dept Surgery | UCLA DGSOM Dept Of Family Medicine | UCLA Division of Cardiology | UCLA Division of Dermatology | UCLA, Division of Hematology/Oncology | UCLA Division of Hematology/oncology, Los Angeles | UCLA Health System | UCLA Integrated Substance Abuse Programs | UCLA JCCC Clinical Research Unit | UCLA / Jonsson Comprehensive Cancer Center | UCLA Jonsson Comprehensive Cancer Center | UCLA/Jonsson Comprehensive Cancer Center | UCLA Jules Stein Eye Institute | UCLA Kidney Transplant Research | UCLA Longevity Center | UCLA Mood Disorders Research Program | UCLA Neurology | UCLA NPI | UCLA Oncology Center | UCLA Professor of Medicine | UCLA Program on Genomics and Nutrition | UCLA Pulmonary Division | UCLA School of Medicine, Study Overall Principal Investigator | UCLA School of Nursing | UCLA School of Public Health | UCLA Semel Institute | UCLA Stroke Center | UCLA Stroke Center, Co-Principal Investigator | UCLA - TORI | UCLA Vice Street Clinic | unaffiliated (Assistant Clinical Professor of Medicine, David Geffen School of Medicine at UCLA) | UNIV CALIFORNIA LOS ANGELES | UNIV CA LOS ANGELES | Univeristy of California, Los Angeles | University California, Los Angeles | University of California at Los Angeles | University of California at Los Angeles (UCLA ) | University of California at Los Angeles (UCLA) | University of California at Los Angeles, UCLA | University of California Geffen School of Medicine | University of California, in Los Angeles, Division of Rheumatology, 310 206 7866 | University of California, Los Angeles | Universityof California Los Angeles | University of California, Los Angeles; Center for the Health Sciences | University of California Los Angeles David Geffen School of Medicine | University of California Los Angeles, Department of Neurosurgery | University of California, Los Angeles, Department of Neurosurgery | University of California, Los Angeles Department of Orhtopaedic Surgery | University of California, Los Angeles, Department of Psychiatry and Biobehavioral Sciences | University of California, Los Angeles, Neuropsychiatric Institute | University of California, Los Angeles - Pulmonary Division | University of California, Los Angeles (UCLA) | University of California, Los Angeles (UCLA), Los Angeles, CA | University of California, Los Angeles (UCLA) Semel Institute for Neuroscience and Human Behavior | University of California , Los Angeles, USA | Walter Ling | Zachary A. Rubin, MD | Zhaoping Li